ArticleBMJ open2025

Single-centre, double-blinded, randomised placebo-controlled trial to determine the effect of a 12-week home-based programme of footplate neuromuscular electrical stimulation on walking capacity in people with peripheral artery disease: a protocol for the Foot-PAD trial.

Christopher David Askew et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.